SPONSOR
Jiangsu Simcere Pharmaceutical Co., Ltd.
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 3
Conditions studied: Advanced Solid TumorsLocally Advanced or Metastatic Breast CancerHealthy Adult ParticipantsNon-Muscle-Invasive Bladder Cancer (NMIBC)
NCT06686745 Phase 1
Recruiting
Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
Advanced Solid Tumors
NCT06680921 Phase 3
Recruiting
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Locally Advanced or Metastatic Breast Cancer
NCT07357610 Phase 1
Recruiting
An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
Healthy Adult Participants
NCT06186414 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
Non-Muscle-Invasive Bladder Cancer (NMIBC)